Le Lézard
Classified in: Science and technology, Business
Subject: PDT

WSGF To Offer Vaycaychella Short-Term Rental P2P Alt Finance App Sneak Peek Next Week


DALLAS, Jan. 28, 2021 /PRNewswire/ -- World Series of Golf, Inc. (OTC Pink: WSGF) ("WSGF"), today announced plans to provide a sneak peek into the company's Vaycaychella short-term rental P2P alternative finance app next week.

Yesterday, through its subsidiary, Vaycaychella, WSGF announced that the company remains on track for the scheduled beta launch of its Vaycaychella fintech short-term rental P2P alternative finance app in February.

WSGF acquired Vaycaychella last year. Vaycaychella is now WSGF's primary business focus.  A corporate name change is underway.

Vaycaychella has built a peer-to-peer (P2P) technology solution designed to connect short-term rental property buyers with alternative investors. The P2P application (app) is part of a fintech ecosystem solution suite for short-term rental property owners that includes a Visa Card solution and plans for a cryptocurrency component.

Over the past three years Vaycaychella has built a portfolio of short-term vacation property investments that would not typically qualify for conventional mortgages. Now the company is scaling its business model with the introduction of its P2P technology.

WSGF plans to beta launch its Vaycaychella P2P app to beta users in February 2021 with a production launch anticipated in June. 

Look for an announcement next week on the coming sneak peek presentation providing an overview of the functionality and look and feel of the Vaycacyhella app.

To learn more and keep up with the latest updates at Vaycaychella, visit  https://www.vaycaychella.com/. At the company website, you will find a blog with frequent industry publications on the short-term rental market in general, as well as entries specific to Vaycaychella.

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

WSGF Contact:
William "Bill" Justice
[email protected]
+1 (800) 871-0376

SOURCE World Series of Golf, Inc.


These press releases may also interest you

at 18:15
Americas Gold and Silver Corporation ("Americas" or the "Company"), a growing North American precious metals producer, reports consolidated financial and operational results for the year ended December 31, 2023. This earnings release should be...

at 18:15
Westhaven Gold Corp. is pleased to announce that it has closed the final tranche of the non-brokered private placement announced on February 20, 2024. Westhaven has issued a total of 7,926,182 common shares that qualify as "flow-through shares" of...

at 18:03
Revenue Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's  sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31. Twelve-month...

at 18:02
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...

at 18:01
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: